Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer (NSCLC)

This publication has 30 references indexed in Scilit:

• European School of Oncology First Euro-American Forum on Lung Cancer Treatment
  European Journal Of Cancer, 1994
• Induction therapy for Stage III NSCLC: A consensus report
  Lung Cancer, 1994
• Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?
  Journal of Clinical Oncology, 1993
• Adverse influence of younger age on outcome in patients with non-small cell lung carcinoma (nsclc) treated with radiation therapy (rt) alone
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Chemotherapy of Lung Cancer
  New England Journal of Medicine, 1992
• Coagulation Abnormalities in Malignancy: A Review
  Seminars in Thrombosis and Hemostasis, 1992
• Chemotherapy of non-small cell lung cancer according to disease extent: a meta-analysis of the literature
  Lung Cancer, 1991
• Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer
  Cancer, 1990
• The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer.
  Journal of Clinical Oncology, 1989
• Lung cancer in young persons
  The Journal of Thoracic and Cardiovascular Surgery, 1982